Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients.
Hocker JR, Deb SJ, Li M, Lerner MR, Lightfoot SA, Quillet AA, Hanas RJ, Reinersman M, Thompson JL, Vu NT, Kupiec TC, Brackett DJ, Peyton MD, Dubinett SM, Burkhart HM, Postier RG, Hanas JS.
Hocker JR, et al. Among authors: hanas js.
Cancer Invest. 2017 Oct 21;35(9):573-585. doi: 10.1080/07357907.2017.1373120. Epub 2017 Sep 26.
Cancer Invest. 2017.
PMID: 28949774